Enterococcus faecalis

Present
The presence of Enterococcus faecalis in a urinary tract infection (UTI) panel indicates an infection caused by this bacterium. Enterococcus faecalis is a gram-positive, facultative anaerobic organism that is a common cause of various infections, including UTIs, particularly in hospital settings or among patients with certain risk factors. These infections can occur in different parts of the urinary tract, including the bladder (cystitis) and the kidneys (pyelonephritis). Enterococcus faecalis is known for its ability to cause infections in several body sites and can be particularly challenging to treat due to its intrinsic resistance to many common antibiotics. It is resistant to cephalosporins, clindamycin, aminoglycosides, and trimethoprim-sulfamethoxazole. Moreover, this bacterium has the capacity to acquire and transfer antibiotic resistance genes, further complicating treatment options. In the context of urinary tract infections, Enterococcus faecalis is usually seen in patients who are chronically ill or hospitalized, especially those with urinary catheters or who have undergone urinary tract instrumentation. Infections caused by Enterococcus faecalis can range from uncomplicated cystitis to more severe infections like pyelonephritis, perinephric abscesses, or chronic prostatitis. These infections may require specific antibiotic therapies, often guided by antibiotic susceptibility testing due to the organism's varied resistance patterns. In summary, the presence of Enterococcus faecalis in a UTI indicates a need for careful selection of antibiotic therapy, considering the organism's resistance profile and the specific clinical scenario of the patient.

Enterococcus faecalis, a notable marker in urinary tract infection (UTI) panels, such as those offered by RealTime Laboratories, is a significant bacterium due to its role in various infections. As a gram-positive, facultative anaerobic organism, E. faecalis is commonly found as part of the normal intestinal flora but can cause a variety of infections including urinary tract infections, endocarditis, and bacteremia.

Urinary tract infections caused by E. faecalis are particularly noteworthy. These infections often occur in chronically ill patients, especially in nosocomial settings, and can be associated with factors like urinary catheterization or obstruction. E. faecalis is capable of causing complicated UTIs, such as pyelonephritis, perinephric abscesses, and chronic prostatitis, which can also lead to bacteremia.

The treatment of E. faecalis infections varies based on the site of infection and susceptibility testing. In the context of urinary tract infections, if the causative organism is sensitive, treatment usually involves a single antibiotic such as ampicillin or amoxicillin. However, E. faecalis has shown intrinsic resistance to several antibiotics, including cephalosporins, clindamycin, aminoglycosides, and trimethoprim-sulfamethoxazole. Additionally, it has gained antibiotic resistance through the acquisition and transfer of resistance-related mobile genetic elements, making the treatment of infections it causes more challenging.

Over the past decades, resistance to multiple antimicrobials, especially among E. faecium, a close relative of E. faecalis, has increased rapidly. This resistance includes aminoglycosides, such as gentamicin and streptomycin, and vancomycin-resistant enterococci (VRE) strains that may also be resistant to other glycopeptides and beta-lactams.

For more detailed information on Enterococcus faecalis and its implications in urinary tract infections, you can refer to resources provided by the Merck Manuals Professional Edition and StatPearls on NCBI Bookshelf.

Enterococcus faecalis
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Enterococcus faecalis — 10,000+ markers explained
One Enterococcus faecalis result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro